Clover Health Investments (CLOV) Projected to Post Earnings on Tuesday

Clover Health Investments (NASDAQ:CLOV) is expected to be releasing its earnings data before the market opens on Tuesday, March 11th. Analysts expect Clover Health Investments to post earnings of ($0.07) per share and revenue of $346.92 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Clover Health Investments Stock Performance

NASDAQ CLOV opened at $3.64 on Friday. Clover Health Investments has a fifty-two week low of $0.61 and a fifty-two week high of $4.87. The stock has a 50 day simple moving average of $4.08 and a two-hundred day simple moving average of $3.62. The stock has a market cap of $1.82 billion, a P/E ratio of -18.20 and a beta of 2.00.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on CLOV shares. Canaccord Genuity Group increased their target price on Clover Health Investments from $4.20 to $4.50 and gave the stock a “buy” rating in a research report on Monday, March 3rd. Craig Hallum started coverage on Clover Health Investments in a research report on Tuesday, December 17th. They issued a “buy” rating and a $6.00 target price for the company.

Insider Activity at Clover Health Investments

In other Clover Health Investments news, CEO Brady Patrick Priest sold 75,000 shares of Clover Health Investments stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.68, for a total value of $276,000.00. Following the completion of the sale, the chief executive officer now owns 2,418,151 shares of the company’s stock, valued at approximately $8,898,795.68. This trade represents a 3.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Karen Soares sold 52,500 shares of Clover Health Investments stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total value of $199,500.00. Following the completion of the sale, the general counsel now directly owns 1,299,663 shares of the company’s stock, valued at approximately $4,938,719.40. The trade was a 3.88 % decrease in their position. The disclosure for this sale can be found here. 22.28% of the stock is owned by corporate insiders.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.